NCATS-supported scientists are engaged in cutting-edge translational research activities across the United States. Read the latest news about CTSA Program researchers that are collaborating locally, regionally and nationally, fostering innovation in training and methodologies to get more treatments to more patients more quickly.
Learn more about the CTSA Program in Action:
- Goal 1: Train and Cultivate the Translational Science Workforce
- Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
- Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
- Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
- Goal 5: Advance the Use of Cutting-Edge Informatics
CTSA Program-supported scientists work to develop novel technique to test drugs against the most common form of brain cancer, glioblastoma multiforme.
- CTSA Program Mentoring Helps Engineers Develop Innovative Rehabilitation Therapies
- NCATS and Eli Lilly Collaborate to Bridge Cultural, Research Divide
- CTSA Program Mentoring Paves Way for Brain Cancer Therapy
CTSA Program-supported researchers developed a community-based research evaluation model to determine the effectiveness of consultation services that help translate clinical practice observations into new treatment approaches.
- NCATS Enables Scientists, Community Clinicians to Collaborate on Health Initiatives
- CTSA Program Hub Expands Successful Radio Show with Podcast
- NCATS Supports Expanded Eye Screening for Underserved Diabetics
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research across the Human Lifespan
Efforts are now underway to add rare diseases to newborn screenings through Early Check, a research program in which voluntary screening for fragile X syndrome and other genetic conditions yet to be determined will be offered to up to 120,000 families each year in North Carolina. NCATS is supporting Early Check through a CTSA Program Collaborative Innovation Award (CCIA).
- Unprecedented Trans-NCATS Collaboration Enables Rapid Advancement of Rare Lung Disease Therapy to Human Trials
- CTSA Program-Supported Research Uncovers Genetic Components of Healthy Aging
- CTSA Program Supports Research Network in Geographically Isolated Region
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
CTSA Program-supported researchers explore the dissemination and clinical implementation of therapies, interventions and policies to ultimately improve human health.
- NCATS Trial Innovation Network Investigators Tackling Clinical Trial Inefficiencies
- CTSA Program-Supported Investigators Validate Biomarkers for NPC1 Treatment
- CTSA Program-Supported Researchers Test Low-Cost Treatment for Deadly Illness
A team of CTSA researchers are developing and evaluating a suite of software tools that will allow all CTSA Program sites to integrate PROMIS tools directly into their electronic health records.
- NCATS Supports Novel Methods to Improve Institutional Review Board Efficiencies
- NCATS-Supported Researchers Recruit Citizen Scientists to Help Mine Biomedical Literature
- CTSA Program Domain Task Forces: Spotlight on Informatics